Kadimastem Ltd (TLV:KDST)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2,499.00
-120.00 (-4.58%)
May 13, 2025, 3:29 PM IDT
421.71%
Market Cap 100.65M
Revenue (ttm) n/a
Net Income (ttm) -26.55M
Shares Out 4.19M
EPS (ttm) -6.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 31,786
Average Volume 17,593
Open 2,619.00
Previous Close 2,619.00
Day's Range 2,451.00 - 2,619.00
52-Week Range 430.00 - 2,797.00
Beta 0.31
RSI 53.02
Earnings Date May 29, 2025

About Kadimastem

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 11
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol KDST
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.